Tuesday, June 30, 2020

China finds 'cholesterol-lowering drugs' to reduce mortality in patients with Covid-19

Animal studies have shown that statins can improve immune cell responses, reduce inflammation, and slow the progression of lung injuries. However, no clinical results have been confirmed. Will be affected by the use of such drugs or not. Whether using the statin drugs alone Or in combination with other drugs

To find the answer Researchers at Renmin Hospital at Wuhan University have studied 13,981 patients in Covid-19 patients at 21 hospitals in Hubei Province, with 1,219 of them receiving the drug. Statin

After a 28-day follow-up, the researchers found that the mortality rate of patients receiving statin drugs was 5.2 percent lower than the mortality rates of patients without medication. Which is 9.4 percent

Numerous patient studies have also revealed that the use of statins has been linked to the statistics of patients with Covid-19. Reducing use of respirators Treatment in intensive care units And the occurrence of acute respiratory distress In addition, people using statins also have a lower incidence of inflammation than those who do not receive the drug. Which indicates that Statin drugs can protect patients from serious illnesses.

The researchers added that 319 patients in the study combined the statin group with ACE Inhibitor (ARBs) and antihypertensive group (ARBs). ) While another 603 patients used statins with other blood pressure medications. The study found that the addition of ACE inhibitors or angiotensin drugs Does not increase the risk of death in patients at all

Li Hong Liang's side The lead research leader said "The results prove the safety and efficacy of the statin group in the treatment of patients with Covid-19 in the hospital", adding that the drug is likely to be able to treat patients with cattle disease - 19, especially at a time when there is no approved vaccine Or there is still no way to cure this type of disease

No comments:

Post a Comment